Work

Supplementary Table S1 from The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development

Year: 2024

Type: supplementary-materials

Abstract: Dose, regiment, DAR, payload, target, and indication(s) for auristatin, maytansinoid, camptothecin, and PBD ADCs and corresponding small molecules

DOI: 10.1158/2159-8290.27435573

Authors: Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, Patricia M. LoRusso, Elisabeth G.E. de Vries

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4403988080

Cites:

Cited by: 1

Related to: 10